Literature DB >> 7747670

The effect of obesity on postmenopausal bone loss and the risk of osteoporosis.

C Ribot1, F Trémollières, J M Pouillès.   

Abstract

There are many data indicating that osteoporotic fractures, and particularly hip fractures, are less frequent in obese subjects. Overweight and obese women have a higher bone mass after menopause than women of the same age who are not overweight, and thus in all probability have a slower bone loss. This protective effect appears to be related both to mechanical factors and to estrogen synthesis in adipose tissue.

Entities:  

Mesh：

Year:  1994        PMID： 7747670     DOI： 10.1007/978-1-4757-9092-4_15

Source DB:  PubMed          Journal:  Adv Nutr Res        ISSN： 0149-9483


  13 in total

1.  Thy1 is a positive regulator of osteoblast differentiation and modulates bone homeostasis in obese mice.

Authors:  Ananta Paine; Collynn F Woeller; Hengwei Zhang; Maria de la Luz Garcia-Hernandez; Nelson Huertas; Lianping Xing; Richard P Phipps; Christopher T Ritchlin
Journal:  FASEB J       Date:  2018-01-17       Impact factor: 5.191

2.  Structural equation modeling of the relationship of bone mineral density and its risk factors in Japanese women.

Authors:  S Toyokawa; H Nishikawa; M Ueji; K Motegi; K Kano
Journal:  Environ Health Prev Med       Date:  2001-04       Impact factor: 3.674

3.  The Relationship Between Body Mass Index and Bone Mineral Density in Premenopausal and Postmenopausal North Indian Women.

Authors:  Ashok Kumar; Aparna K Sharma; Soniya Mittal; Guresh Kumar
Journal:  J Obstet Gynaecol India       Date:  2014-10-29

4.  The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome.

Authors:  Consuelo Buttigliero; Federica Vana; Valentina Bertaglia; Francesca Vignani; Cristian Fiori; Giangiacomo Osella; Francesco Porpiglia; Marcello Tucci; Giorgio Vittorio Scagliotti; Alfredo Berruti
Journal:  Endocrine       Date:  2015-01-15       Impact factor: 3.633

5.  Mice chronically fed a westernized experimental diet as a model of obesity, metabolic syndrome and osteoporosis.

Authors:  Christian Demigné; May Bloch-Faure; Nicolas Picard; Houda Sabboh; Catherine Besson; Christian Rémésy; Valérie Geoffroy; Anh-Thu Gaston; Antonino Nicoletti; Albert Hagège; Joël Ménard; Pierre Meneton
Journal:  Eur J Nutr       Date:  2006-04-28       Impact factor: 5.614

6.  Changes in serum runt-related transcription factor 2 levels after a 6-month treatment with recombinant human parathyroid hormone in patients with osteoporosis.

Authors:  W Zhu; M L Yang; G Y Yang; G Boden; L Li
Journal:  J Endocrinol Invest       Date:  2011-11-21       Impact factor: 4.256

7.  Changes in bone mineral density over time by body mass index in the health ABC study.

Authors:  J T Lloyd; D E Alley; M C Hochberg; S R Waldstein; T B Harris; S B Kritchevsky; A V Schwartz; E S Strotmeyer; C Womack; D L Orwig
Journal:  Osteoporos Int       Date:  2016-02-08       Impact factor: 4.507

8.  Relationship of body mass index with main limb fragility fractures in postmenopausal women.

Authors:  Saverio Gnudi; Emanuela Sitta; Lucia Lisi
Journal:  J Bone Miner Metab       Date:  2009-03-10       Impact factor: 2.626

9.  Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass.

Authors:  G Lupoli; C Di Carlo; V Nuzzo; G Vitale; D Russo; S Palomba; C Nappi
Journal:  J Endocrinol Invest       Date:  1997-09       Impact factor: 4.256

10.  Natural history and risk factors for bone loss in postmenopausal Caucasian women: a 15-year follow-up population-based study.

Authors:  G Zhai; D J Hart; A M Valdes; B S Kato; J B Richards; A Hakim; T D Spector
Journal:  Osteoporos Int       Date:  2008-02-28       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.